09. November 2016

Ethylene vinyl acetate (EVA) copolymer has a record of successfully serving the pharmaceutical industry as a controlled release excipient. EVA has shown excellent stability, processability and versatility in the controlled release of selected oral administered drugs via hot melt extrusion. In this literature review, you will discover: Information on EVA in oral drug delivery Many polymers have been used in oral formulations to provide various functions, including controlled release. EVA’s...

19. September 2016

Improving drug delivery to the eye with Celanese EVA polymers DALLAS and BOSTON, Mass. (September 15, 2016) – Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present “Driving Ophthalmic Drug Delivery Innovation with EVA” on Tuesday, September 20 at the 2016 Targeting Ocular Disorders Conference in Boston, Mass. “Celanese is working with its customers to develop state-of-the-art drug delivery systems using our pharmaceutical material...

30. June 2016

VITALDOSE® EVA—AN EFFECTIVE DRUG DELIVERY TECHNOLOGY Our custom controlled release ethylene vinyl acetate, VitalDose® EVA, is improving pharmaceutical drug delivery applications around the world. VitalDose EVA is safe and dependable, and has performed effectively in controlled release applications for more than 20 years. Attend our technical presentation to see how our controlled release EVA is improving drug delivery technology. Join us at the 2016 Controlled Release Society (CRS) Annual...